Life Science Consulting & Transaction Advisory for Pharmaceutical and Biotech Operators
Pharma and biotech transactions sit at the intersection of manufacturing, regulatory, operational, and financial considerations. We advise pharmaceutical companies, biotech innovators, and financial sponsors through real estate, M&A, due diligence, and licensing transactions.
Services
What we do
Life Sciences Real Estate
PharmaBioSource leads life science real estate transactions for biotech, pharma, and CDMO operators. From manufacturing facilities to lab and R&D space, our brokers structure acquisitions, dispositions, and lease arrangements that align with pipeline timelines and operational requirements.
M&A Consulting
We provide pharma competitive intelligence, market sizing, and strategic advisory for pharmaceutical and biotech executives evaluating M&A opportunities. Our consultants assess therapeutic area fit, valuation drivers, and post-transaction integration risk before a deal moves into formal execution.
Sell-Side Advisory
PharmaBioSource leads sell-side M&A advisory mandates for pharmaceutical asset owners. We position the asset, build the buyer universe, prepare the Confidential Information Memorandum, and run negotiations through closing. Our advisors are senior practitioners with operating experience in pharma manufacturing.
Buy-Side Advisory
Our team supports pharmaceutical and biotech buyers through pharma buy-side advisory mandates. We help define the acquisition thesis, source qualified targets, lead diligence, and structure negotiations that protect deal economics.
Due Diligence Services
PharmaBioSource delivers outsourcing pharma due diligence for private equity, venture capital, and corporate buyers evaluating pharmaceutical and biotech investments. We assess manufacturing readiness, regulatory standing, supply chain risk, and cost of goods so deal teams enter negotiations on defensible footing.
Product Licensing
PharmaBioSource structures and negotiates licensing transactions through our pharma out-licensing service and in-licensing advisory. We position assets, identify partners, model manufacturing economics, and close term sheets that capture upfront value while protecting royalty and milestone economics over the deal lifecycle.
Our Geographic Coverage
PharmaBioSource leads transactions across North America, Europe, and Asia, with experience navigating cross-border manufacturing, regulatory filing requirements, and territory carve-outs. Our team has supported clients through transactions involving facilities, partners, and counterparties spanning the United States, Canada, the European Union, the United Kingdom, and key Asian markets.
FEATURED TRANSACTIONS
Inside the work
Pharmaceutical and biotech mandates, operator-led from kickoff to close.
Explore pharmaceutical facilities currently for sale
Looking for a GMP manufacturing facility, a biologics plant, or a sterile injectable suite? PharmaBioSource brokers active listings, confidential mandates, and sale-leasebacks for qualified buyers.